Call 1-877-744-5675

Select a product to learn about specific resources.

Prescribing Information

Learn more

VISIT IBRANCE HCP SITE

Tools and resources for patients prescribed IBRANCE® (palbociclib).

FREE 1-MONTH (21-DAY) TRIAL VOUCHER FOR NEW IBRANCE PATIENTS

New patients who have been prescribed IBRANCE can start a free 1-month (21-day) trial with this voucher, regardless of insurance coverage.

Limits, terms, and conditions apply. This 1-month trial voucher is not a prescription for IBRANCE. To utilize this voucher, the patient must have a valid prescription. By using this voucher, there is no obligation on the patient or healthcare provider to continue IBRANCE.

To continue on IBRANCE, a healthcare provider must write a separate prescription to be filled at a participating specialty pharmacy. This trial voucher is valid once per patient for a 1-month (21-day) trial of 125 mg, 100 mg, or 75 mg capsules through 12/31/2019. Pfizer reserves the right to rescind, revoke or amend this offer without notice. For any questions, please call 1-844-9-IBRANCE or write: Pfizer Inc, 235 E. 42nd Street, New York, NY 10017.

VISIT SITE

IBRANCE ANSWERS

Do your patients have questions about IBRANCE? How could they not? IBRANCE Answers delivers tips, lifestyle content, and important information directly to patients and their loved ones. They’ll also receive a free starter kit with useful materials like our patient brochure, caregiver guide, pill organizer, and journal.

Patients can register on IBRANCE.com.

VISIT SITE

IBRANCE AMBASSADORS

Your patients may find inspiration in hearing from IBRANCE Patient and Caregiver Ambassadors—a team of real IBRANCE patients and those who care about them. See what IBRANCE Ambassadors are sharing about what they’ve learned, how they’re coping, and ways they’re managing daily life.

The IBRANCE Ambassador Mentor Program offers women taking IBRANCE—as well as their caregivers—the opportunity to talk on the phone privately, one-on-one with an IBRANCE patient or caregiver ambassador to share stories and experiences.

Ambassadors were asked to share their personal stories about IBRANCE. All content was accurate at the time of publication and may have since changed. Mentors are not medical or mental health professionals and cannot provide any medical advice.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed IBRANCE, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT TALZENNA HCP SITE

Tools and resources for patients prescribed TALZENNA®(talazoparib).

TALZENNA Materials

Pfizer is developing educational materials to help support people who are taking TALZENNA. Patients can visit TALZENNA.com for more information.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed TALZENNA, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT XALKORI HCP SITE

Tools and resources for patients prescribed XALKORI® (crizotinib).

XALKORI PATIENT RESOURCES

Patients can sign up for ongoing support directly though the registration form on the XALKORI website. The program is designed to help patients learn more about XALKORI and receive a patient brochure and other helpful information.

Patients can register on XALKORI.com.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

Financial Assistance

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed XALKORI, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT LORBRENA HCP SITE

Tools and resources for patients prescribed LORBRENA® (lorlatinib).

LORBRENA MATERIALS

Pfizer is developing educational materials to help support people who are taking LORBRENA. Patients can sign up on LORBRENA.com to receive future communications and materials.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed LORBRENA, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT INLYTA HCP SITE

Tools and resources for patients prescribed INLYTA® (axitinib).

Free 1-Month (30-Day) TRIAL VOUCHER FOR NEW INLYTA PATIENTS

New patients who have been prescribed INLYTA can start a free 1-month (30-day) trial with this voucher, regardless of insurance coverage.

Limits, terms, and conditions apply. This 1-month trial voucher is not a prescription for INLYTA. To utilize this voucher, the patient must have a valid prescription. By using this voucher, there is no obligation on the patient or healthcare provider to continue INLYTA.

To continue on INLYTA, a healthcare provider must write a separate prescription to be filled at a participating specialty pharmacy. This trial voucher is valid once per patient for a 1-month (30-day) trial of 1 mg or 5 mg tablets through 12/31/2019. Pfizer reserves the right to rescind, revoke or amend this offer without notice. For any questions, please call 1-877-744-5675 or write: Pfizer Inc, 235 E. 42nd Street, New York, NY 10017.

GET VOUCHER

INLYTA PATIENT KIT

The INLYTA patient resource kit is filled with useful tools, including:

  • A brochure with information about INLYTA
  • A pill organizer
  • Information about financial assistance resources

To access the INLYTA patient kit, contact Pfizer Oncology Together. For a downloadable patient brochure, visit INLYTAhcp.com.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed INLYTA, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT TORISEL HCP SITE

Tools and resources for patients prescribed TORISEL® (temsirolimus).

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed TORISEL, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT VIZIMPRO HCP SITE

Tools and resources for patients prescribed VIZIMPRO® (dacomitinib).

VIZIMPRO MATERIALS

Pfizer is developing educational materials to help support people who are taking VIZIMPRO. Patients can visit VIZIMPRO.com for more information.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed VIZIMPRO, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT BOSULIF HCP SITE

Tools and resources for patients prescribed BOSULIF® (bosutinib).

Free 1-Month (30-Day) Trial Voucher for New BOSULIF Patients

New patients who have been prescribed BOSULIF can start a free 1-month (30-day) trial with this voucher, regardless of insurance coverage.

Limits, terms, and conditions apply. This 1-month trial voucher is not a prescription for BOSULIF. To utilize this voucher, the patient must have a valid prescription. By using this voucher, there is no obligation on the patient or healthcare provider to continue BOSULIF.

To continue on BOSULIF, a healthcare provider must write a separate prescription to be filled at a participating specialty pharmacy. This trial voucher is valid once per patient for a 1-month (30-day) trial of 500 mg, 400 mg, or 100 mg tablets through 3/31/2020. Pfizer reserves the right to rescind, revoke or amend this offer without notice. For any questions, please call 1-855-541-5929 or write: Pfizer Inc, 235 E. 42nd Street, New York, NY 10017.

GET VOUCHER

BOSULIF STEPS

The BOSULIF STEPS brochure contains information and resources that are available to patients taking BOSULIF.

VIEW BROCHURE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed BOSULIF, regardless of their insurance coverage.

LEARN MORE

Please see full Prescribing Information for SUTENT, including BOXED WARNING for hepatotoxicity, or visit SUTENThcp.com.

Learn more

VISIT SUTENT HCP SITE

Tools and resources for patients prescribed SUTENT® (sunitinib malate).

Free 1-Month (28-Day) Trial Voucher for NEW SUTENT PATIENTS

New patients who have been prescribed SUTENT can start a free 1-month (28-day) trial with this voucher, regardless of insurance coverage.

Limits, terms, and conditions apply. This 1-month trial voucher is not a prescription for SUTENT. To utilize this voucher, the patient must have a valid prescription. By using this voucher, there is no obligation on the patient or healthcare provider to continue SUTENT.

To continue on SUTENT, a healthcare provider must write a separate prescription to be filled at a participating specialty pharmacy. This trial voucher is valid once per patient for a 1-month (28-day) trial of 12.5 mg, 25 mg, 37.5 mg, or 50 mg capsules through 12/31/2019. Pfizer reserves the right to rescind, revoke or amend this offer without notice. For any questions, please call 1-877-744-5675 or write: Pfizer Inc, 235 E. 42nd Street, New York, NY 10017.

GET VOUCHER

SUTENT Resource Kit

The SUTENT patient resource kit is filled with useful tools, including:

  • A brochure with information about SUTENT 
  • A pill organizer
  • Information about financial assistance resources

To get a SUTENT patient resource kit, patients can contact Pfizer Oncology Together.

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed SUTENT, regardless of their insurance coverage.

LEARN MORE

Please see full Prescribing Information for DAURISMO, including BOXED WARNING for embryo-fetal toxicity, or visit DAURISMOhcp.com.

Learn more

VISIT DAURISMO HCP SITE

Tools and resources for patients prescribed DAURISMO (glasdegib).

DAURISMO MATERIALS

Pfizer is developing educational materials to help support people who are taking DAURISMO. Patients can visit DAURISMO.com to download a brochure with information about DAURISMO.

VISIT SITE

PERSONALIZED PATIENT SUPPORT

Care Champions at Pfizer Oncology Together are ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed DAURISMO, regardless of their insurance coverage.

LEARN MORE

Please see full Prescribing Information for BESPONSA, including BOXED WARNING for hepatotoxicity, including VOD, and increased risk of post-HSCT non-relapse mortality, or visit BESPONSAhcp.com.

Learn more

VISIT BESPONSA HCP SITE

Tools and resources for patients prescribed BESPONSA
(inotuzumab ozogamicin)
.

PERSONALIZED PATIENT SUPPORT

Pfizer Oncology Together is ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed BESPONSA, regardless of their insurance coverage.

LEARN MORE

Please see full Prescribing Information for MYLOTARG, including BOXED WARNING for hepatotoxicity, or visit MYLOTARGhcp.com.

Learn more

VISIT MYLOTARG HCP SITE

Tools and resources for patients prescribed MYLOTARG
(gemtuzumab ozogamicin)
.

PERSONALIZED PATIENT SUPPORT

Pfizer Oncology Together is ready to listen to patients and connect them to resources that may help with some of their day-to-day challenges.

LEARN MORE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed MYLOTARG, regardless of their insurance coverage.

LEARN MORE

Prescribing Information

Learn more

VISIT BAVENCIO HCP SITE

Tools and resources for patients prescribed BAVENCIO® (avelumab).

COVERONE®

This program provides patient access and reimbursement support services to help patients gain appropriate access to BAVENCIO in the United States.

VISIT SITE

DIGITAL PATIENT BROCHURES

These brochures offer an easy-to-print version of the information on BAVENCIO.com.

VISIT SITE

PATIENT WALLET CARD

This card includes important information about BAVENCIO. Patients can show it to their doctors to help keep their healthcare team informed about the medications they’re taking.

VISIT SITE

BAVENCIO (avelumab) is jointly developed and commercialized by Merck KGaA, Darmstadt, Germany and Pfizer.

Prescribing Information

Learn more

VISIT AROMASIN HCP SITE

Tools and resources for patients prescribed AROMASIN® (exemestane).

AROMASIN SAVINGS CARD

The AROMASIN Savings Card can help eligible, commercially insured patients save on their prescribed brand-name AROMASIN.*

VISIT SITE

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed AROMASIN, regardless of their insurance coverage.

LEARN MORE

*Eligibility required. Terms and conditions apply. Full terms and conditions can be found at  AROMASIN.com/savings-terms. Savings Offer will be accepted only at participating pharmacies. Savings Offer is not health insurance. No membership fees. Maximum savings $3,600 per year. This offer is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare or other federal or state healthcare programs. This offer is not valid for prescriptions that are eligible to be reimbursed in whole by private insurance plans or other health or pharmacy benefit programs. For further information, call 1-866-562-6151, visit  AROMASIN.com, or write: AROMASIN Savings Offer, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

EMCYT®
(estramustine phosphate sodium)

Prescribing Information

Learn more

 

Tools and resources for patients prescribed EMCYT®
(estramustine phosphate sodium)
.

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed EMCYT, regardless of their insurance coverage.

LEARN MORE

ZINECARD®
(dexrazoxane)

Prescribing Information

Learn more

 

Tools and resources for patients prescribed ZINECARD® (dexrazoxane).

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed ZINECARD, regardless of their insurance coverage.

LEARN MORE

CAMPTOSAR®
(irinotecan hydrochloride)

Please see full Prescribing Information for CAMPTOSAR, including BOXED WARNINGS for diarrhea and severe myelosuppression, or visit pfizerpro.com.

Learn more

 

Tools and resources for patients prescribed CAMPTOSAR®
(irinotecan hydrochloride)
.

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed CAMPTOSAR, regardless of their insurance coverage.

LEARN MORE

ELLENCE®
(epirubicin hydrochloride)

Please see full Prescribing Information for ELLENCE, including BOXED WARNINGS for myocardial toxicity, severe myelosuppression, secondary acute myelogenous leukemia (AML), dosing, and administration, or visit pfizerpro.com.

Learn more

 

Tools and resources for patients prescribed ELLENCE®
(epirubicin hydrochloride)
.

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed ELLENCE, regardless of their insurance coverage.

LEARN MORE

IDAMYCIN®
(idarubicin hydrochloride)

Please see full Prescribing Information for IDAMYCIN, including BOXED WARNINGS for myocardial toxicity, severe myelosuppression, dosing, and administration, or visit pfizerpro.com.

Learn more

 

Tools and resources for patients prescribed IDAMYCIN®
(idarubicin hydrochloride)
.

FINANCIAL ASSISTANCE

Pfizer Oncology Together can help identify financial assistance resources for patients prescribed IDAMYCIN, regardless of their insurance coverage.

LEARN MORE

BACK TO TOP